Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma
Brief Summary: Ovarian carcinoma has poor prognosis and new therapeutic strategies are required. Many patients with ovarian carcinoma showed resistance to chemotherapy. Cleaved FasL is known for induced atypical response when is binding to Fas such as avoiding apoptosis and inducing cell motility.